Home › Polycystic Ovary Syndrome › NCT06633120
In Vitro Maturation of Human Eggs
Who can join
Up to age 38 · Women
Full eligibility criteria
Inclusion Criteria: * Infertile women diagnosed with PCOS or polycystic ovaries, or infertile women with good ovarian reserve * Antral follicle count (AFC) greater than 24 * AMH greater than 3.5 ng/ml * Body Mass Index less than 35 * Accept to have embryos biopsied for PGT * Intend to perform embryo transfer within 4 months after completing the IVM cycle * Paternal (or donor) age \<45, ejaculated sperm collection only (partner frozen and donor sperm acceptable), sperm morphology (strict criteria) \>1%, motility \> 20% and sperm count \> 10 million per ml (so samples can be prepared through standard procedure) Exclusion Criteria: * More than 2 failed IVF cycles
About the study
CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication
What is being tested
- IVM (other)
Sponsor: Colorado Center for Reproductive Medicine · Participants: 50 · Started: Feb 3, 2023
Contact the study team
- Elizabeth A Jannaman, BS · Phone: 303-788-8300
- Ye Yuan, PhD · Phone: 720-895-8306
Official record on ClinicalTrials.gov — NCT06633120
Locations in the U.S.
| Colorado | Colorado Center for Reproductive Medicine, Lone Tree |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.